MAXIMUS, Inc.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: US5779331041
USD
84.57
-0.29 (-0.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About MAXIMUS, Inc. stock-summary
stock-summary
MAXIMUS, Inc.
Miscellaneous
MAXIMUS, Inc. provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs. The Health Services segment provides a range of BPS, as well as related consulting services, for state, provincial and national government programs. The Human Services segment provides national, state and local human services agencies with a range of BPS and related consulting services for welfare-to-work, child support, higher education and K-12 special education programs.
Company Coordinates stock-summary
Company Details
1891 Metro Center Dr , RESTON VA : 20190-5287
stock-summary
Tel: 1 703 25185001 703 2518637
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 106 Schemes (63.82%)

Foreign Institutions

Held by 163 Foreign Institutions (20.83%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Peter Pond
Non-Executive Independent Chairman of the Board
Mr. Bruce Caswell
President, Chief Executive Officer, Director
Mr. Richard Montoni
Vice Chairman and Senior Advisor to the Chief Executive Officer
Mr. John Haley
Director
Ms. Jan Madsen
Director
Ms. Anne Altman
Independent Director
Ms. Gayathri Rajan
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1,348 Million
(Quarterly Results - Jun 2025)
Net Profit:
106 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 4,978 Million (Small Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.90

stock-summary
Return on Equity

17.88%

stock-summary
Price to Book

2.81